1 min read
Celebrating The Success of Velcade | 14 Years Later
Last week, Veristat attended the Massachusetts Biotechnology Council (MassBio) forum titled “Evolution of an Academic Discovery: First Person Account of the Development of Velcade®”.
Blog | Think Bold, Think Scientific, Think Veristat
Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.
Sign Up Today
Featured (3)
1 min read
Veristat Participates in Cycle for Survival 2017 and Raises over $25,000 to Fund Rare Cancer Research
February 23, 2017
On Saturday, February 4, Team Veristat joined the battle against rare cancers at the 2017 Cycle for Survival event! Team Veristat had 14 riders at the Boston, MA event, including 2 colleagues from our UK office. Our team surpassed our goal of raising...
3 min read
Be a Trusted Friend
January 5, 2017
For anyone who follows this blog with even moderate consistency, it is probably clear that Veristat is a growing organization. It is hopefully just as apparent that we are a group who tremendously values and fiercely protects our culture.
2 min read
How Do You Make Informed Decisions about Implementing Adaptive Designs?
December 15, 2016
Read more about this and the discussions that you missed at the MassBio Forum on Adaptive Designs in Clinical Research that took place last month.